ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.
D001327:Autoimmune Diseases / Q000188:drug therapy; D002056:Burns / Q000188:drug therapy; D003550:Cystic Fibrosis / Q000188:drug therapy; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy
D016756:Immunoglobulins, Intravenous